Cargando…
Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service
SUMMARY: In this cross-sectional study, two-thirds of Fracture Liaison Service (FLS) patients had comorbidities and medications associated with increased bone- or fall-related fracture risk. Bone-related and fall-related fracture risk (BRR and FRR) were associated with age and fracture type, but not...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818578/ https://www.ncbi.nlm.nih.gov/pubmed/29170857 http://dx.doi.org/10.1007/s00198-017-4290-y |
_version_ | 1783301052245737472 |
---|---|
author | Vranken, L. Wyers, C. E. Van der Velde, R. Y. Janzing, H. M. Kaarsemaker, S. Geusens, P. P. Van den Bergh, J. P. |
author_facet | Vranken, L. Wyers, C. E. Van der Velde, R. Y. Janzing, H. M. Kaarsemaker, S. Geusens, P. P. Van den Bergh, J. P. |
author_sort | Vranken, L. |
collection | PubMed |
description | SUMMARY: In this cross-sectional study, two-thirds of Fracture Liaison Service (FLS) patients had comorbidities and medications associated with increased bone- or fall-related fracture risk. Bone-related and fall-related fracture risk (BRR and FRR) were associated with age and fracture type, but not with gender or BMD. Systematic evaluation of these factors leads to a more profound assessment in FLS care. INTRODUCTION: This study is a systematic evaluation of comorbidities and medications associated with increased fracture risk in patients aged 50–90 years with a recent fracture visiting the FLS. METHODS: In this cross-sectional cohort study, comorbidities were classified according to ICD-10 and medications according to the Anatomic Therapeutic Chemical (ATC) classification and further categorized into those associated BRR and FRR. RESULTS: Of 1282 patients (72% women; 65 ± 9 years), 53% had at least one BRR, 46% had at least one FRR, and 66% at least one BRR and/or FRR. At least one BRR, as well as at least one FRR were associated with age, BMI, and fracture type, but not with gender or BMD. The proportion of patients with only BRR (± 20%) or only FRR (± 10%) was similar among ages, gender, BMI, fracture type, and BMD. The combination of at least one BRR and at least one FRR was significantly associated with age, BMI, and major fractures, but not with gender or BMD. CONCLUSION: Comorbidities and medications associated with increased fracture risk are present in two-thirds of patients visiting the FLS. In addition, the proportion of patients having a combination of BRR and FRR increased significantly with age, BMI, and fracture severity. This indicates that systematic evaluation of these factors is important for a more profound assessment of subsequent fracture risk in FLS care. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00198-017-4290-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5818578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer London |
record_format | MEDLINE/PubMed |
spelling | pubmed-58185782018-02-27 Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service Vranken, L. Wyers, C. E. Van der Velde, R. Y. Janzing, H. M. Kaarsemaker, S. Geusens, P. P. Van den Bergh, J. P. Osteoporos Int Original Article SUMMARY: In this cross-sectional study, two-thirds of Fracture Liaison Service (FLS) patients had comorbidities and medications associated with increased bone- or fall-related fracture risk. Bone-related and fall-related fracture risk (BRR and FRR) were associated with age and fracture type, but not with gender or BMD. Systematic evaluation of these factors leads to a more profound assessment in FLS care. INTRODUCTION: This study is a systematic evaluation of comorbidities and medications associated with increased fracture risk in patients aged 50–90 years with a recent fracture visiting the FLS. METHODS: In this cross-sectional cohort study, comorbidities were classified according to ICD-10 and medications according to the Anatomic Therapeutic Chemical (ATC) classification and further categorized into those associated BRR and FRR. RESULTS: Of 1282 patients (72% women; 65 ± 9 years), 53% had at least one BRR, 46% had at least one FRR, and 66% at least one BRR and/or FRR. At least one BRR, as well as at least one FRR were associated with age, BMI, and fracture type, but not with gender or BMD. The proportion of patients with only BRR (± 20%) or only FRR (± 10%) was similar among ages, gender, BMI, fracture type, and BMD. The combination of at least one BRR and at least one FRR was significantly associated with age, BMI, and major fractures, but not with gender or BMD. CONCLUSION: Comorbidities and medications associated with increased fracture risk are present in two-thirds of patients visiting the FLS. In addition, the proportion of patients having a combination of BRR and FRR increased significantly with age, BMI, and fracture severity. This indicates that systematic evaluation of these factors is important for a more profound assessment of subsequent fracture risk in FLS care. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00198-017-4290-y) contains supplementary material, which is available to authorized users. Springer London 2017-11-23 2018 /pmc/articles/PMC5818578/ /pubmed/29170857 http://dx.doi.org/10.1007/s00198-017-4290-y Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Vranken, L. Wyers, C. E. Van der Velde, R. Y. Janzing, H. M. Kaarsemaker, S. Geusens, P. P. Van den Bergh, J. P. Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service |
title | Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service |
title_full | Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service |
title_fullStr | Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service |
title_full_unstemmed | Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service |
title_short | Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service |
title_sort | comorbidities and medication use in patients with a recent clinical fracture at the fracture liaison service |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818578/ https://www.ncbi.nlm.nih.gov/pubmed/29170857 http://dx.doi.org/10.1007/s00198-017-4290-y |
work_keys_str_mv | AT vrankenl comorbiditiesandmedicationuseinpatientswitharecentclinicalfractureatthefractureliaisonservice AT wyersce comorbiditiesandmedicationuseinpatientswitharecentclinicalfractureatthefractureliaisonservice AT vanderveldery comorbiditiesandmedicationuseinpatientswitharecentclinicalfractureatthefractureliaisonservice AT janzinghm comorbiditiesandmedicationuseinpatientswitharecentclinicalfractureatthefractureliaisonservice AT kaarsemakers comorbiditiesandmedicationuseinpatientswitharecentclinicalfractureatthefractureliaisonservice AT geusenspp comorbiditiesandmedicationuseinpatientswitharecentclinicalfractureatthefractureliaisonservice AT vandenberghjp comorbiditiesandmedicationuseinpatientswitharecentclinicalfractureatthefractureliaisonservice |